Domain Generalization: A Survey.

IEEE Trans Pattern Anal Mach Intell

Published: April 2023

Generalization to out-of-distribution (OOD) data is a capability natural to humans yet challenging for machines to reproduce. This is because most learning algorithms strongly rely on the i.i.d. assumption on source/target data, which is often violated in practice due to domain shift. Domain generalization (DG) aims to achieve OOD generalization by using only source data for model learning. Over the last ten years, research in DG has made great progress, leading to a broad spectrum of methodologies, e.g., those based on domain alignment, meta-learning, data augmentation, or ensemble learning, to name a few; DG has also been studied in various application areas including computer vision, speech recognition, natural language processing, medical imaging, and reinforcement learning. In this paper, for the first time a comprehensive literature review in DG is provided to summarize the developments over the past decade. Specifically, we first cover the background by formally defining DG and relating it to other relevant fields like domain adaptation and transfer learning. Then, we conduct a thorough review into existing methods and theories. Finally, we conclude this survey with insights and discussions on future research directions.

Download full-text PDF

Source
http://dx.doi.org/10.1109/TPAMI.2022.3195549DOI Listing

Publication Analysis

Top Keywords

domain generalization
8
domain
5
learning
5
generalization survey
4
survey generalization
4
generalization out-of-distribution
4
out-of-distribution ood
4
data
4
ood data
4
data capability
4

Similar Publications

People attribute purposes in both mundane and profound ways-such as when thinking about the purpose of a knife and the purpose of a life. In three studies (total = 13,720 observations from = 3,430 participants), we tested whether these seemingly very different forms of purpose attributions might actually involve the same cognitive processes. We examined the impacts of four factors on purpose attributions in six domains (artifacts, social institutions, animals, body parts, sacred objects, and human lives).

View Article and Find Full Text PDF

The application of nanotechnology in medical biology has seen a significant rise in recent years because of the introduction of novel tools that include supramolecular systems, complexes, and composites. Dendrimers are one of the remarkable examples of such tools. These spherical, regularly branching structures with enhanced cell compatibility and bioavailability have shown to be an excellent option for gene or drug administration.

View Article and Find Full Text PDF

Cognitive stimulation to improve cognitive functioning in people with dementia.

Cochrane Database Syst Rev

January 2023

Research Department of Clinical, Educational and Health Psychology, University College London, London, UK.

Background: Cognitive stimulation (CS) is an intervention for people with dementia offering a range of enjoyable activities providing general stimulation for thinking, concentration and memory, usually in a social setting, such as a small group. CS is distinguished from other approaches such as cognitive training and cognitive rehabilitation by its broad focus and social elements, aiming to improve domains such as quality of life (QoL) and mood as well as cognitive function. Recommended in various guidelines and widely implemented internationally, questions remain regarding different modes of delivery and the clinical significance of any benefits.

View Article and Find Full Text PDF

Intracellular spatiotemporal chemical heterogeneities with controlled properties are essential for life. However, creating these heterogeneities artificially is challenging. In this study, we used both acid- and base-producing enzymatic reactions simultaneously and demonstrated that the execution of these reactions in the presence of audible sound can effectively create spatiotemporally ordered pH domains in a solution.

View Article and Find Full Text PDF

Antibody-based pharmaceuticals are the leading biologic drug platform (> $75B/year). Despite a wealth of information collected on them, there is still a lack of knowledge on their inter-domain structural distributions, which impedes innovation and development. To address this measurement gap, we have developed a new methodology to derive biomolecular structure ensembles from distance distribution measurements via a library of tagged proteins bound to an unlabeled and otherwise unmodified target biologic.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!